MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells

(2014) Xian-wei Ye et al.   Clinical Respiratory Journal

MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer

(2013) Huijun Zhang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Genes and Pathology of Non-Small Cell Lung Carcinoma

(2013) Shingo Sakashita et al.   SEMINARS IN ONCOLOGY

MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma

(2012) Wen Wang et al.   CARCINOGENESIS

MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene

(2012) Xia Liu et al.   CELL CYCLE

Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)

(2011) Qi Wang et al.   EXPERIMENTAL LUNG RESEARCH

miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner

(2011) Nora Bandi et al.   Molecular Cancer

MicroRNA-138 Modulates DNA Damage Response by Repressing Histone H2AX Expression

(2011) Y. Wang et al.   MOLECULAR CANCER RESEARCH

MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells

(2011) Shipeng Feng et al.   NUCLEIC ACIDS RESEARCH

miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non–Small Cell Lung Cancer

(2009) Nora Bandi et al.   CANCER RESEARCH

Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines

(2008) Shingo Mitomo et al.   CANCER SCIENCE

Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway

(2008) H.Dean Hosgood et al.   CARCINOGENESIS

Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors

(2008) Christina Justenhoven et al.   INTERNATIONAL JOURNAL OF CANCER